@article{26949,
  keywords = {Young Adult, uganda, Time Factors, Socioeconomic Factors, onchocerciasis, Nigeria, Medication adherence, Male, Ivermectin, Humans, Female, Endemic Diseases, Drug Administration Schedule, Child, Cameroon, Antiparasitic Agents, Adult, Adolescent},
  author = {Amazigo U and Wanji S and Ndyomugyenyi R and Elhassan E and Brieger W and Okeibunor J and Abiose A},
  title = {Characteristics of persons who complied with and failed to comply with annual ivermectin treatment.},
  abstract = {<p><strong>OBJECTIVE: </strong>To assess individual compliance with annual ivermectin treatment in onchocerciasis-endemic villages.</p>

<p><strong>METHODS: </strong>Multi-site study in eight APOC-sponsored projects in Cameroon, Nigeria and Uganda to identify the socio-demographic correlates of compliance with ivermectin treatment. A structured questionnaire was administered on 2305 persons aged 10 years and above. Two categories of respondents were purposively selected to obtain both high and low compliers: people who took ivermectin 6-8 times and 0-2 times previously. Simple descriptive statistics were employed in characterizing the respondents into high and low compliers, while some socio-demographic and key perceptual factors were employed in regression models constructed to explain levels of compliance among the respondents.</p>

<p><strong>RESULTS: </strong>Some demographic and perceptual factors associated with compliance were identified. Compliance was more common among men (54.4%) (P &lt; 0.001). Adults (54.6%) had greater rates of high compliance (P &lt; 0.001. The mean age of high compliers (41.5 years) was significantly older (35.8 years) (t = 8.46, P &lt; 0.001). Perception of onchocerciasis and effectiveness of ivermectin influenced compliance. 81.4% of respondents saw benefits in annual ivermectin treatment, high compliance among those who saw benefits was 59.3% compared to 13.3% of those who did not (P &lt; 0.001).</p>

<p><strong>CONCLUSION: </strong>Efforts to increase compliance with ivermectin treatment should focus on providing health education to youth and women. Health education should also highlight the benefits of taking ivermectin.</p>
},
  year = {2012},
  journal = {Tropical medicine & international health : TM & IH},
  volume = {17},
  pages = {920-30},
  issn = {1365-3156},
  doi = {10.1111/j.1365-3156.2012.03007.x},
  note = {<p>&nbsp;</p>

<p>&nbsp;
<p>&nbsp;</p>
</p>
},
  language = {eng},
}